The Vietnam Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $40.8 Mn by 2030, registering a CAGR of 5.73% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, and stroke along with improving healthcare infrastructure in Vietnam. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen, Pfizer Inc. & Vietnam Pharmaceutical Corporation.
The Vietnam Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $40.8 Mn by 2030, registering a CAGR of 5.73% during the forecast period of 2022 - 2030. In Vietnam, 721 clinical trials were registered, 209 of which are active trials. Clinical research organisations have lately increased their focus in Vietnam. There are an estimated 660000 Vietnamese persons living with dementia, with dementia-related expenses totalling US$ 960 Mn. Every year, around 200,000 stroke victims are registered in Vietnam. The frequency of neurological illnesses such as Alzheimer's, Parkinson's, and stroke is growing in Vietnam, necessitating the development of novel treatments and therapies. Moreover, Vietnam has a population of over 96 Mn inhabitants and a fast-expanding healthcare system, making it an appealing location for clinical trials.
The healthcare infrastructure in Vietnam is developing, with new hospitals and clinics being established around the nation. This has expanded the number of prospective clinical trial locations while also improving healthcare service quality, making it simpler to enrol participants for studies. The pharmaceutical sector in Vietnam is also expanding, with both domestic and foreign pharmaceutical businesses investing in R&D. As a result, the number of clinical studies in the nation has increased, particularly neurology clinical trials.
The Ministry of Health (MOH) and the National Ethics Committee (NEC) supervise the regulatory regime for clinical trials in Vietnam. The MOH has developed guidelines for international-standard clinical trials, and the NEC analyses and authorizes all clinical trials before they may begin. In addition, to encourage and facilitate clinical research, the government has developed a nationwide clinical trial network.
Market Growth Drivers
The frequency of neurological illnesses such as Alzheimer's, Parkinson's, and stroke is growing in Vietnam, prompting the development of novel treatments and therapies. Vietnam's healthcare system is developing, with new healthcare facilities being established around the nation. This has raised the potential of new clinical trial execution while also improving the healthcare service quality. The pharmaceutical business in Vietnam is expanding, with both local and multinational pharmaceutical firms engaging in R&D. As a result, the number of clinical studies in the nation has increased, particularly neurology clinical trials. The Ministry of Health (MOH) and the National Ethics Council (NEC) supervise the regulatory framework for clinical trials in Vietnam, and they have developed guidelines for clinical studies that correspond with international standards.
In Vietnam, there is a scarcity of competent investigators and personnel, which might make conducting clinical trials challenging, especially in complex fields like neurology. The language barrier may make conducting clinical trials in Vietnam difficult, especially for international sponsors who may lack access to multilingual personnel or translators. More awareness and education about the relevance of clinical trials and their potential benefits are needed among patients and the general public. Many people may be reluctant to enrol in clinical trials because they may not understand the procedure or the possible advantages. Despite the rising pharmaceutical business, there is still a lack of financing and resources for clinical trials, which might make doing research in Vietnam difficult.
In May 2022, Eisai Vietnam Co., Ltd. announced the inauguration of a new office and the signing of a four-year collaboration agreement with the Vietnam Association of Neurology, commemorating the company's strong 30-year presence in the Vietnamese market.
1. Report Description of the Vietnam Neurology Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Vietnam Neurology Clinical Trials Market Executive Summary
2.1 Vietnam Neurology Clinical Trials Market –Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Vietnam Neurology Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Vietnam Neurology Clinical Trials Market Segmentation
4.1 By Phase
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV
4.2 By Study Design Outlook
4.2.2 Parkinson's Disease (PD)
4.2.3 Huntington's Disease
4.2.5 Traumatic Brain Injury (TBI)
4.2.6 Amyotrophic Lateral Sclerosis (ALS)
4.2.7 Muscle regeneration
4.3 By Indication Outlook
4.3.3 Expanded Access
5. Vietnam Neurology Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Vietnam
8.2 Regulatory Framework in Vietnam
8.3 Pricing & Reimbursement Scenario in Vietnam Neurology Clinical Trials Market
9. Factors Driving Future Growth
9.1 New Trends and Development Vietnam Neurology Clinical Trials Market
9.2 Future Opportunities
10. Strategic Recommendations
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses